Recalls / Class II
Class IID-1064-2016
Product
Tazorac (tazarotene) Gel 0.05%, Rx only, packaged in a) 30g (NDC 0023-8335-03) and b) 100g (NDC 0023-8335-10) tubes, Allergan Inc, Irvine, CA 92612
- Affected lot / code info
- Lot #: a) 84172, b) 84173, Exp FEB/2017
Why it was recalled
Failed Content Uniformity Specifications.
Recalling firm
- Firm
- Allergan Sales, LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 8301 Mars Dr, N/A, Waco, Texas 76712-6578
Distribution
- Quantity
- 17802 units
- Distribution pattern
- Nationwide and Puerto Rico
Timeline
- Recall initiated
- 2016-05-10
- FDA classified
- 2016-07-06
- Posted by FDA
- 2016-07-13
- Terminated
- 2017-12-06
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-1064-2016. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.